ST3GAL2 is a highly significant predictive and prognostic marker in breast cancer patients Given the functional connection between SSEA4 and ST3GAL2 , we evaluated the clinical value of ST3GAL2 in a large, publicly available clinical microarray database of breast tumors from 2977 patients [ 15 ].
← all excerpts
The sialyl-glycolipid stage-specific embryonic antigen 4 marks a subpopulation of chemotherapy-resistant breast cancer cells with mesenchymal features.
1
—
—